Financial Performance - The company experienced strong growth in Q2 2025, with adjusted diluted EPS up by 201%[7] - Adjusted operating income increased by 161%[7] and net revenues grew by 68%[7] - For H1 2025, adjusted diluted EPS increased by 161%[8], adjusted operating income by 145%[8], and net revenues by 65%[8] - The company is raising its 2025 forecast to 13-15% adjusted diluted EPS growth[6] Smoke-Free Products (SFP) - Smoke-free products are driving total volume growth[10], with H1 2025 shipment volume increasing by 131%[10] - Smoke-free net revenues and gross profit showed organic growth of 270%[11] and 154%[11] respectively in H1 2025 - The company's multicategory strategy is catalyzing SFP user growth to over 41 million[17] - IQOS quarterly net revenues are over $3 billion[19] ZYN (Nicotine Pouches) - ZYN nicotine pouch shipment volumes increased by 43%[22] in Q2 2025 compared to the previous year - U S ZYN volumes increased by 41%[22] and international volumes excluding Nordics increased by 179%[22] - The company expects strong H2 offtake growth for ZYN as retail availability normalizes[31] Regional Performance - Europe experienced a 135%[25] growth in IQOS, ZYN & VEEV shipment in Q2 2025 - In Japan, the company's HTU adjusted IMS grew by 78%[26] in Q2 2025, with a 48%[26] HnB offtake category share - The company is seeing excellent IQOS key city progress across global markets[34]
PMI(PM) - 2025 Q2 - Earnings Call Presentation